Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GH Research ( (GHRS) ) has provided an update.
On April 30, 2026, GH Research PLC completed an underwritten public offering of 6,527,779 ordinary shares at $18.00 per share, raising estimated net proceeds of about $111.2 million after fees. The transaction, priced a day earlier and led by Stifel and Cantor Fitzgerald with support from several specialist healthcare investors, adds substantial capital to the balance sheet.
The company plans to deploy the funds to advance research, clinical and technical development of its depression therapies in the U.S. and overseas, as well as to support pre-commercialization, working capital and general corporate needs. The successful equity raise underscores investor confidence in GH Research’s pipeline and bolsters its ability to progress treatment-resistant depression programs through later-stage development.
The most recent analyst rating on (GHRS) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on GH Research stock, see the GHRS Stock Forecast page.
Spark’s Take on GHRS Stock
According to Spark, TipRanks’ AI Analyst, GHRS is a Neutral.
The score is held back primarily by weak financial performance (no revenue, widening losses, and ongoing cash burn), partly offset by a strong, low-leverage balance sheet. Technicals are supportive with clear upward trend and positive momentum, while valuation remains a drag due to negative earnings and no dividend.
To see Spark’s full report on GHRS stock, click here.
More about GH Research
GH Research PLC is a Dublin-based, clinical-stage biopharmaceutical company focused on developing novel mebufotenin-based therapies for treatment-resistant depression. The company aims to deliver a practice-changing depression treatment, targeting patients who do not respond to existing therapies, and is listed on Nasdaq under the ticker GHRS.
Average Trading Volume: 224,170
Technical Sentiment Signal: Buy
Current Market Cap: $1.19B
For a thorough assessment of GHRS stock, go to TipRanks’ Stock Analysis page.